E-Co for Malignancies
Phase-Based Progress Estimates
Effectiveness
Safety
University of Rochester, Rochester, NY
Malignancies+1 More
E-Co - BehavioralEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
The objective of the study is to evaluate the feasibility of a combined mobile health exercise and cognitive rehabilitation intervention and its effect on cognition in a single-arm pilot study that recruits cancer survivors.
Eligible Conditions
- Malignancies
- Older Cancer Survivors (Any Cancer, Aged 60 and Over, Have Completed Curative Intent Treatments)
Treatment Effectiveness
Effectiveness Progress
Other trials for Malignancies
Study Objectives
2 Primary · 4 Secondary · Reporting Duration: Post-intervention at week 12
Week 12
Cambridge Neuropsychological Test Automated Battery (CANTAB)
Controlled Oral Word Association (COWA)
Hopkins Verbal Learning Test-Revised (HVLT-R)
Self-reported cognition
Post-intervention at week 12
Feasibility
Feasibility of the intervention
Trial Safety
Safety Progress
Other trials for Malignancies
Trial Design
1 Treatment Group
E-Co
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: E-Co · No Placebo Group · N/A
E-Co
Behavioral
Experimental Group · 1 Intervention: E-Co · Intervention Types: BehavioralTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: post-intervention at week 12
Trial Background
Prof. Kah Poh Loh, Assistant Professor
Principal Investigator
University of Rochester
Closest Location: University of Rochester · Rochester, NY
2013First Recorded Clinical Trial
10 TrialsResearching Malignancies
554 CompletedClinical Trials
Eligibility Criteria
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You are ≥60 years at the time of consent.
You have completed curative intent treatments.
You have a score of ≤10 on the FACT-Cog Impact of Quality of Life Scale21.
You have an ECOG performance status of 0-3.
You are able to walk 4 meters.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments